Physician profile
Edward Berzin
NPI 1962448241
$7,501.18
in general payments reported to CMS, 2019-2025
26 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,230 · 2020: $454 · 2021: $1,159 · 2022: $783 · 2023: $909 · 2024: $524 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,738 · Travel and Lodging: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.77 |
| Travel and Lodging | $137.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,871.62 | 2019-2022 | |
| Mentor Worldwide LLC | $853.95 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $786.69 | 2021-2025 | |
| Biom'Up France Sas | $531.17 | 2020-2021 | |
| Smith+Nephew, INC. | $494.87 | 2019-2024 | Collagenase Santyl, Regranex |
| Axogen | $352.41 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Tela Bio, INC. | $306.20 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $272.77 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Durasorb Monofilament Mesh |
| Sientra, INC. | $223.74 | 2020-2022 | |
| Merz North America, INC. | $141.74 | 2021 | |
| Medline Industries LP | $139.92 | 2019-2021 | |
| Abbvie INC. | $108.61 | 2023-2025 | Alloderm |
| Checkpoint Surgical, INC | $77.78 | 2019-2024 | Checkpoint Stimulators |
| Stryker Corporation | $57.73 | 2019-2024 | Spy-Phi System |
| Teleflex LLC | $35.56 | 2025 | Quikclot |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $31.56 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $27.74 | 2021 | |
| Misonix INC | $26.35 | 2020 | |
| Tepha INC | $25.24 | 2019 | |
| Biom'Up Sa | $23.17 | 2019 | |
| Davol INC. | $21.84 | 2020 | |
| Aroa Biosurgery Incorporated | $20.61 | 2023 | |
| Coopersurgical, INC. | $19.88 | 2025 | Advincula Delineator Uterine Manipulator |
| Kerecis Limited | $17.94 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ethicon US, LLC | $16.09 | 2021 | |
| Wound Management Technologies, INC | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Berzin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.